Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan · Delayed Price · Currency is JPY 292.00
-1.00 (-0.34%)
May 8, 2026, 3:30 PM JST
Taiko Pharmaceutical Market Cap
Taiko Pharmaceutical has a market cap or net worth of 14.67 billion as of May 8, 2026. Its market cap has increased by 19.81% in one year.
Market Cap
14.67B
Enterprise Value
11.23B
Revenue
6.40B
Ranking
n/a
PE Ratio
15.89
Stock Price
292.00
Market Cap Chart
Since March 18, 2009, Taiko Pharmaceutical's market cap has increased from 10.71B to 14.67B, an increase of 36.94%. That is a compound annual growth rate of 1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 14.67B | -2.01% |
| Dec 30, 2025 | 14.97B | -9.87% |
| Dec 30, 2024 | 16.61B | 10.16% |
| Dec 29, 2023 | 15.08B | -12.28% |
| Dec 30, 2022 | 17.19B | -52.12% |
| Dec 30, 2021 | 35.91B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daito Pharmaceutical | 35.33B |
| Mizuho Medy | 33.43B |
| Fuso Pharmaceutical Industries,Ltd. | 18.77B |
| Pharma Foods International | 17.95B |
| Wakamoto Pharmaceutical | 12.42B |
| Morishita Jintan | 9.04B |
| Solasia Pharma K.K. | 8.74B |
| Cyfuse Biomedical K.K. | 6.75B |